Glucose and lipid metabolism disease
Conditions
Interventions
Case series:None
Sponsors
Guangdong Pharmaceutical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Those who meet the diagnosis of pre-type 2 diabetes, type 2 diabetes, diabetic nephropathy, diabetic coronary heart disease, hyperlipidemia, non-alcoholic fatty liver disease, essential hypertension, and atherosclerotic cardiovascular disease; 2. Aged 18-75 years; 3. The patients voluntarily participated in this study and had good compliance; 4. Syndrome differentiation belongs to liver stagnation and spleen deficiency syndrome, phlegm dampness block syndrome, damp-heat internal accumulation syndrome, qi and yin deficiency syndrome, spleen and kidney yang deficiency syndrome, phlegm and blood stasis syndrome, and yang deficiency and turbidity syndrome (Diagnostic standard reference: Diagnosis and Treatment Specifications of Integrative Traditional Chinese and Western Medicine for Diabetes and Lipid Metabolism Diseases (Convulsion)).
Exclusion criteria
Exclusion criteria: 1. Poor patient compliance; 2. Pregnant and lactating patients; 3. Patients with acute cardiovascular and cerebrovascular events, diabetic ketosis, acidosis, hyperosmolar coma, etc.; 4. Patients with malignant tumor; 5. Those who did not sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose;Lipids;Carotid artery intima-media thickness;Glycated hemoglobin; | — |
Countries
China
Contacts
Public ContactGuo Jiao
Guangdong Pharmaceutical University
Outcome results
None listed